Svelte 30 Nutritional Consultants Issues a Voluntary Recall of Weight Loss Pills Found to Contain an Undeclared Drug Ingredient

Svelte 30 Nutritional Consultants Issues a Voluntary Recall of Weight Loss Pills Found to Contain an Undeclared Drug Ingredient
Wed, 23 Feb 2011 16:57:00 -0600

Svelte 30 Nutritional Consultants has been informed by the Food and Drug Administration (FDA) that a sample of Svelte 30 orange & gray capsule was collected and tested by FDA in January 2011. The capsules tested positive for Sibutramine, an FDA-approved drug used as an appetite suppressant for weight loss.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@govdelivery.com
• Other inquiries? webmail@oc.fda.gov

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420